Your browser doesn't support javascript.
loading
Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.
Fitzgerald, Kathryn C; Morris, Bridget; Soroosh, Aurash; Balshi, Alexandra; Maher, Dermot; Kaplin, Adam; Nourbakhsh, Bardia.
Afiliação
  • Fitzgerald KC; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA/Department of Epidemiology, Johns Hopkins University School of Public Health, Baltimore, MD, USA.
  • Morris B; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Soroosh A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Balshi A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Maher D; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kaplin A; Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Nourbakhsh B; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mult Scler ; 27(6): 942-953, 2021 05.
Article em En | MEDLINE | ID: mdl-32633662
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ketamina / Esclerose Múltipla Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ketamina / Esclerose Múltipla Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article